1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "945721-28-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-P9915
    Daratumumab

    Anti-Human CD38, Human Antibody

    Others Cancer Inflammation/Immunology
    Daratumumab (Anti-Human CD38) is the first-in-class human-specific anti-CD38 monoclonal antibody. Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition.